Sensei Biotherapeutics Earnings Estimate

SNSE Stock  USD 9.09  0.25  2.83%   
By analyzing Sensei Biotherapeutics' earnings estimates, investors can diagnose different trends across Sensei Biotherapeutics' analyst sentiment over time as well as compare current EPS estimates against different timeframes. Please be aware that the consensus of earnings estimates for Sensei Biotherapeutics is based on EPS before non-recurring items and includes expenses related to employee stock options.
 
Covid
 
Interest Hikes
Sensei Biotherapeutics is projected to generate -4.5425 in earnings per share on the 31st of December 2025. Sensei Biotherapeutics earnings estimates show analyst consensus about projected Sensei Biotherapeutics EPS (Earning Per Share). It derives the highest and the lowest estimates based on Sensei Biotherapeutics' historical volatility. Many public companies, such as Sensei Biotherapeutics, manage the perception of their earnings on a regular basis to make sure that analyst estimates are accurate. Future earnings calculations are also an essential input when attempting to value a firm. By analyzing Sensei Biotherapeutics' earnings estimates, investors can diagnose different trends across Sensei Biotherapeutics' analyst sentiment over time as well as compare current estimates against different timeframes. As of February 15, 2026, Gross Profit is expected to decline to about (520.7 K)Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Sensei Biotherapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in producer price index.
For information on how to trade Sensei Stock refer to our How to Trade Sensei Stock guide.

Sensei Biotherapeutics Earnings per Share Projection vs Actual

About Sensei Biotherapeutics Earnings Estimate

The earnings estimate module is a useful tool to check what professional financial analysts are assuming about the future of Sensei Biotherapeutics earnings. We show available consensus EPS estimates for the upcoming years and quarters. Investors can also examine how these consensus opinions have evolved historically. We show current Sensei Biotherapeutics estimates, future projections, as well as estimates 1, 2, and three years ago. Investors can search for a specific entity to conduct investment planning and build diversified portfolios. Please note, earnings estimates provided by Macroaxis are the average expectations of expert analysts that we track. If a given stock such as Sensei Biotherapeutics fails to match professional earnings estimates, it usually performs purely. Wall Street refers to that as a 'negative surprise.' If a company 'beats' future estimates, it's usually called an 'upside surprise.'
Please read more on our stock advisor page.
Last ReportedProjected for Next Year
Retained Earnings-235.8 M-247.6 M
Earnings Yield(0.14)(0.13)
Price Earnings Ratio(7.35)(7.71)
Price Earnings To Growth Ratio 4.48  4.71 

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether Sensei Biotherapeutics is a strong investment it is important to analyze Sensei Biotherapeutics' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Sensei Biotherapeutics' future performance. For an informed investment choice regarding Sensei Stock, refer to the following important reports:
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Sensei Biotherapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in producer price index.
For information on how to trade Sensei Stock refer to our How to Trade Sensei Stock guide.
You can also try the USA ETFs module to find actively traded Exchange Traded Funds (ETF) in USA.
Will Biotechnology sector continue expanding? Could Sensei diversify its offerings? Factors like these will boost the valuation of Sensei Biotherapeutics. If investors know Sensei will grow in the future, the company's valuation will be higher. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Sensei Biotherapeutics data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Earnings Share
(19.14)
Return On Assets
(0.37)
Return On Equity
(0.70)
Investors evaluate Sensei Biotherapeutics using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating Sensei Biotherapeutics' intrinsic value - the estimated true worth - helps identify when the stock trades at a discount or premium to fair value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. External factors like market trends, sector rotation, and investor psychology can cause Sensei Biotherapeutics' market price to deviate significantly from intrinsic value.
Please note, there is a significant difference between Sensei Biotherapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Sensei Biotherapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. Conversely, Sensei Biotherapeutics' market price signifies the transaction level at which participants voluntarily complete trades.